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A B S T R A C T
Spontaneous pneumothorax is a rare complication of pneumocystis jirovecii pneumonia. We report a patient
with pneumocystis jirovecii pneumonia and therapy-refractory, right-sided pneumothorax due to persistent air
leak (PAL) despite prolonged chest tube placement and multiple pleurodesis attempts. Due to the patient's
morbidity, we evaluated if the PAL can be sealed by unidirectional endobronchial valves (EBVs). After occlusion
of the right upper lobe by a balloon catheter, the air leak ﬂow-rate decreased from 800 ml/min to 250 ml/min.
Zephyr EBVs (ZEBVs) were placed in the segmental right upper lobe bronchi and subsequently, a complete
resolution of the pneumothorax was noted. During 30 months of follow-up, neither recurrence of pneumothorax
nor any adverse events of EBV treatment were noted. We conclude that ZEBV placement might be an eﬀective
and well-tolerated treatment option for PAL secondary to pneumocystis jirovecii pneumonia with promising
long-term results.
1. Introduction
Persistent air leak (PAL) of the lung is deﬁned as an abnormal
communication between the bronchial tree or the alveolar space and
the pleural cavity which may lead to pneumothorax [1]. PAL can occur
spontaneously or can result from thoracic surgery or chronic lung dis-
eases. Spontaneous pneumothorax occurs in up to 2% of patients suf-
fering from pneumocystis jirovecii pneumonia [2].
The therapy of PAL can be challenging, especially in the critically ill
patient. If prolonged chest tube placement with or without pleurodesis
is not eﬃcacious, some patients will require surgical interventions.
However, many critically ill patients are poor surgical candidates.
Therefore, bronchoscopic attempts have been made using diﬀerent
devices like tissue glue, gel foam, silver nitrate, autologous blood pat-
ches, spigots or stents [3]. As none of these methods has shown sig-
niﬁcant eﬃcacy to replace surgical intervention, the placement of
unidirectional intrabronchial valves using ﬂexible bronchoscopy has
been evaluated, showing promising results as an alternative and less
invasive treatment of PAL [1].
2. Case report
A 42-year-old man with human immunodeﬁciency virus infection
and acquired immune deﬁciency syndrome (AIDS) presented to the
emergency department with bilateral pneumonia. His anti-retroviral
therapy with emtricitabin, tenofovir and raltegravin was continued and
he received intravenous antibiotic treatment with piperacillin and ta-
zobactam 4.5 g tid. Rapid respiratory failure shortly after admission
required immediate orotracheal intubation and mechanical ventilation.
Computed tomographic pulmonary angiography excluded acute pul-
monary embolism but revealed bilateral pulmonary inﬁltrates suspi-
cious for pneumocystis jirovecii pneumonia and a right-sided pneu-
mothorax (Fig. 1). A chest tube with continuous suction of−20 cmH2O
was placed. Flexible bronchoscopy with broncho-alveolar lavage de-
tected pneumocystis jirovecii. The patient was started on trimethoprim-
sulfamethoxazole 20/100 mg/kg qid. Intravenous prednisolone was
administered due to severe hypoxemia. Subsequently, the respiratory
situation improved and the patient could be weaned and extubated
after seven days of ventilator support.
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However, pneumothorax persisted and chest tube evacuation re-
vealed right-sided PAL despite multiple pleurodesis attempts using
doxycycline. Therefore, and due to the patient's signiﬁcant morbidity
(AIDS, severe bilateral pneumonia with hypoxemia, cachexia), we
decided to evaluate if the PAL might be successfully sealed by uni-
directional endobronchial valves (EBVs). A ﬂexible bronchoscopy in
deep sedation was performed and the air leak ﬂow-rate was con-
tinuously measured using a medela pump (Medela GmbH & Co.,
Dietersheim, Germany). After occlusion of the right upper lobe seg-
mental bronchi by a balloon catheter (Teleﬂex Medical Europe Ltd.,
Athlone, Ireland), ﬂow-rate decreased from 800 ml/min to 250 ml/min.
As balloon occlusion on sub-segmental level of the right upper lobe did
not achieve similar results, the segmental bronchi were occluded using
3 Zephyr EBVs (ZEBV 5.5 mm, ZEBV 4.0 mm, ZEBV 4.0 LP, Pulmonx
Inc., Neuchâtel, Switzerland). Subsequently, resolution of the pneu-
mothorax was noted and the air leak ﬂow completely ceased. The chest
tube was removed eight days after EBV treatment, and the patient could
be discharged after 52 days in hospital. Removal of the valves was of-
fered to the patient eight weeks after discharge from the hospital;
however, he refused another bronchoscopy. During 30 months of
follow-up, neither recurrence of pneumothorax nor any adverse events
of EBV treatment were noted (Fig. 2).
3. Discussion
The use of unidirectional intrabronchial valves in the treatment of
PAL has been described several times since 2005 [1]. Most patients
suﬀered from post-operative PAL, suppurative lung disease or sponta-
neous pneumothorax [3]. To date, there exists only one report in the
current literature about EBV treatment of PAL secondary to pneumo-
cystis jirovecii pneumonia [4].
In a recent review, EBV treatment for pneumothorax secondary to
PAL was found to be eﬀective and well-tolerated with resolution rates
between 48 and 100% and rare complications like infection, ex-
pectoration or migration of the valves [3]. However, in most previous
case reports, EBVs were removed four to eight weeks after resolution of
the PAL in order to minimise the risk of side eﬀects [1]. None of these
case series report long-term follow-up results.
To our best knowledge, this is the ﬁrst report of successful EBV
therapy in a patient with PAL secondary to pneumocystis jirovecii
pneumonia with a long-term follow-up. We conclude that ZEBV pla-
cement might be an eﬀective and well-tolerated treatment option for
PAL secondary to pneumocystis jirovecii pneumonia with promising
long-term results.
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Fig. 1. Thoracic computed tomographic scan revealing bilateral pulmonary inﬁltrates suspicious for pneumocystis jirovecii pneumonia and a right-sided pneu-
mothorax.
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consent was obtained from the patient. The institutional review board
at the Klinikum Augsburg waived the need for an ethical approval for
this case report.
Appendix A. Supplementary data
Supplementary data related to this article can be found at https://
doi.org/10.1016/j.rmcr.2018.08.021.
Fig. 2. Chest X-ray before (A) and 30 months after EBV placement revealing complete and sustained resolution of the right-sided pneumothorax (B).
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